Skip to playerSkip to main content
  • 6 hours ago
A booming global beauty treatment market is using donated skin from deceased Americans as an ingredient in injectable cosmetic treatments. Millions of dollars’ worth of donated skin have been shipped from US tissue banks to South Korean biotech companies, where it is processed for cosmetic use. Business Insider investigated how this donated tissue travels from American donors to Korean clinics and how much money the industry makes.

Category

🤖
Tech
Transcript
00:00There's a new beauty treatment that's surging in popularity around the globe,
00:03and it relies on an unusual ingredient, skin from dead Americans.
00:07Each year, tens of thousands of Americans donate bodily tissue, like skin, upon their deaths.
00:12Tens of millions of dollars worth of that skin has been supplied to companies in the beauty capital of the
00:16world, South Korea.
00:18There, skin is turned into injectable cosmetic treatments.
00:20They're called skin boosters, and they promise to reduce signs of aging.
00:23The market-leading brand plans to enter the U.S. next year,
00:26but it isn't clear if it can be sold here without regulatory approval.
00:29Business Insider traces supply chain to understand how American donor tissue can end up for sale at a clinic in
00:35Seoul
00:35and how much money is being made along the way.
00:37Under U.S. law, donors or their families cannot be paid for tissue or organs.
00:41Using human tissue in plastic surgery isn't new.
00:44For decades, cartilage has been used in nose jobs and skin in breast augmentations.
00:48Now, skin care from human tissue can be purchased for a few hundred dollars
00:51and administered at a med spa or dermatology clinic in under an hour.
00:55In South Korea, a mecca for cutting-edge beauty treatments,
00:57at least 10 biotech firms are making or planning to introduce skin-derived injections.
01:01These products are projected to generate $75 million in sales this year in South Korea.
01:06The distribution of organs is coordinated by a public-private partnership with the federal government,
01:11but tissue is handled differently.
01:13It's distributed through commercial relationships.
01:15The more traditional business aspects of the tissue industry have been a subject of debate for decades.

Recommended